Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001439222-25-000104
Filing Date
2025-09-30
Accepted
2025-09-30 17:56:01
Documents
1
Period of Report
2025-09-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1759269358.html 4  
1 FORM 4 wk-form4_1759269358.xml 4 7378
  Complete submission text file 0001439222-25-000104.txt   8898
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AGIOS THERAPEUTICS, INC. 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Jones Cecilia (Reporting) CIK: 0001840056 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 251361806